Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AstraZeneca claims new immunosuppressants for asthma, bronchitis, rhinitis, etc.

July 22, 1999

New antiasthmatic agent in the pipeline at Nikken Chemicals

July 22, 1999

Novel series of PDE4 inhibitors from Byk Gulden particularly useful for asthma prophylaxis

July 22, 1999

Genset seeks patents for two genes associated with zileuton-induced hepatotoxicity

July 22, 1999

Zambon presents phthalazines useful for Rx of inflammatory/allergic disorders

July 20, 1999

Xanthines acting as inhibitors of PDE4 and/or TNF claimed by Darwin Discovery

July 19, 1999

Dihydrobenzofuran bronchial therapeutics in development at Byk Gulden

July 16, 1999

BTG acquires technology for cytokine inhibition

July 16, 1999

Superoxide dimutase product may reduce asthma and neurodevelopmental deficits in neonates

July 15, 1999

Yoshitomi describes potent, selective tryptase inhibitors

July 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...